BACKGROUND: In 2008, the US Congress enacted the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act (MHPAEA) requiring insurers to equalize private insurance coverage for mental health and substance use disorder services with coverage for general medical services. OBJECTIVE: To examine the effects of MHPAEA on substance use disorder treatment. STUDY DESIGN: We used a difference-in-differences design to compare changes in outcomes among plan enrollees in the years before and after implementation of federal parity (2009-2010) with changes in outcomes among a comparison group of enrollees previously covered by state substance use disorder parity laws. METHODS: Insurance claims data from Aetna Inc health plans in 10 states with state parity laws were used to compare outcomes for plan enrollees in fully insured and self-insured health plans (N = 298,339). RESULTS: In the first year of implementation, we found that federal parity did not lead to changes in the proportion of enrollees using substance use disorder treatment. We did find a modest increase in spending on substance use disorder treatment per enrollee ($9.99, 95% confidence interval, 2.54-18.21), but no significant change in identification, treatment initiation, or treatment engagement. CONCLUSIONS: Inclusion of substance use disorder services in the federal parity law did not result in substantial increases in health plan spending. It will be critical to study results for year 2 after regulations affecting the management of care (eg, utilization review, network access) take effect.
BACKGROUND: In 2008, the US Congress enacted the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act (MHPAEA) requiring insurers to equalize private insurance coverage for mental health and substance use disorder services with coverage for general medical services. OBJECTIVE: To examine the effects of MHPAEA on substance use disorder treatment. STUDY DESIGN: We used a difference-in-differences design to compare changes in outcomes among plan enrollees in the years before and after implementation of federal parity (2009-2010) with changes in outcomes among a comparison group of enrollees previously covered by state substance use disorder parity laws. METHODS: Insurance claims data from Aetna Inc health plans in 10 states with state parity laws were used to compare outcomes for plan enrollees in fully insured and self-insured health plans (N = 298,339). RESULTS: In the first year of implementation, we found that federal parity did not lead to changes in the proportion of enrollees using substance use disorder treatment. We did find a modest increase in spending on substance use disorder treatment per enrollee ($9.99, 95% confidence interval, 2.54-18.21), but no significant change in identification, treatment initiation, or treatment engagement. CONCLUSIONS: Inclusion of substance use disorder services in the federal parity law did not result in substantial increases in health plan spending. It will be critical to study results for year 2 after regulations affecting the management of care (eg, utilization review, network access) take effect.
Authors: Deborah W Garnick; Margaret T Lee; Mady Chalk; David Gastfriend; Constance M Horgan; Frank McCorry; A Thomas McLellan; Elizabeth Levy Merrick Journal: J Subst Abuse Treat Date: 2002-12
Authors: Howard H Goldman; Richard G Frank; M Audrey Burnam; Haiden A Huskamp; M Susan Ridgely; Sharon-Lise T Normand; Alexander S Young; Colleen L Barry; Vanessa Azzone; Alisa B Busch; Susan T Azrin; Garrett Moran; Carolyn Lichtenstein; Margaret Blasinsky Journal: N Engl J Med Date: 2006-03-30 Impact factor: 91.245
Authors: Susan T Azrin; Haiden A Huskamp; Vanessa Azzone; Howard H Goldman; Richard G Frank; M Audrey Burnam; Sharon-Lise T Normand; M Susan Ridgely; Alexander S Young; Colleen L Barry; Alisa B Busch; Garrett Moran Journal: Pediatrics Date: 2007-02 Impact factor: 7.124
Authors: K John McConnell; Samuel H N Gast; M Susan Ridgely; Neal Wallace; Natalie Jacuzzi; Traci Rieckmann; Bentson H McFarland; Dennis McCarty Journal: Am J Psychiatry Date: 2011-09-02 Impact factor: 18.112
Authors: Rebecca L Haffajee; Michelle M Mello; Fang Zhang; Alisa B Busch; Alan M Zaslavsky; J Frank Wharam Journal: Med Care Date: 2019-04 Impact factor: 2.983
Authors: Jessica M Harwood; Francisca Azocar; Amber Thalmayer; Haiyong Xu; Michael K Ong; Chi-Hong Tseng; Kenneth B Wells; Sarah Friedman; Susan L Ettner Journal: Med Care Date: 2017-02 Impact factor: 2.983
Authors: Susan L Ettner; Jessica M Harwood; Amber Thalmayer; Michael K Ong; Haiyong Xu; Michael J Bresolin; Kenneth B Wells; Chi-Hong Tseng; Francisca Azocar Journal: J Health Econ Date: 2016-09-30 Impact factor: 3.883
Authors: Sarah A Friedman; Amber G Thalmayer; Francisca Azocar; Haiyong Xu; Jessica M Harwood; Michael K Ong; Laura Lambert Johnson; Susan L Ettner Journal: Health Serv Res Date: 2016-12-12 Impact factor: 3.402
Authors: Marguerite E Burns; Laura Dague; Brendan Saloner; Kristen Voskuil; Nam Hyo Kim; Natalia Serna Borrero; Kevin Look Journal: Health Serv Res Date: 2020-06-23 Impact factor: 3.402
Authors: Alene Kennedy-Hendricks; Andrew J Epstein; Elizabeth A Stuart; Rebecca L Haffajee; Emma E McGinty; Alisa B Busch; Haiden A Huskamp; Colleen L Barry Journal: Pediatrics Date: 2018-08 Impact factor: 7.124